Peter Barrett, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 137,100 shares at $16.06 ($2.2M) on 2006-03-02, disclosed to the SEC on 2006-03-03.
Open-market sale of $2.2M ALNY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.06 | 396 | $6K | 0.3% |
| 2 | $16.06 | 790 | $13K | 0.6% |
| 3 | $16.06 | 1,166 | $19K | 0.9% |
| 4 | $16.06 | 5,907 | $95K | 4.3% |
| 5 | $16.06 | 23,777 | $382K | 17.3% |
| 6 | $16.06 | 43,164 |
| $693K |
| 31.5% |
| 7 | $16.06 | 326 | $5K | 0.2% |
| 8 | $16.06 | 651 | $10K | 0.5% |
| 9 | $16.06 | 959 | $15K | 0.7% |
| 10 | $16.06 | 4,862 | $78K | 3.5% |
| 11 | $16.06 | 19,572 | $314K | 14.3% |
| 12 | $16.06 | 35,530 | $571K | 25.9% |
| Total | $16.06 avg | 137,100 | $2.2M | 100% |
| Filing → |
| PKI | SELL | 2017-11-14 | $1.0M | — | Filing → |
| PKI | SELL | 2017-06-02 | $632K | — | Filing → |
| VTAE | BUY | 2014-10-01 | $300K | — | Filing → |